乌尔索酸调节雌激素转化以通过HSD17B14缓解代谢功能障碍相关的脂肪性肝病中的炎症
Simin Gu1, Hui Zhang2, Zhekun Xiong2
1Department of Gastroenterology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Journal of clinical and translational hepatology
|April 10, 2025
概括
乌尔索酸通过调节17β-基类固醇脱酶14 (HSD17B14) 来治疗与代谢功能障碍相关的脂肪性肝病 (MASLD). 这种作用会使雌激素水平重新平衡,减少脂肪性肝细胞的炎症.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是一个日益严重的全球健康问题.
- 乌尔索酸显示了MASLD的治疗潜力,需要阐明机制.
- 雌激素代谢在MASLD病变发生过程中发挥作用.
研究的目的:
- 调查MASLD中乌尔索酸的治疗机制.
- 探索乌尔索酸如何调节MASLD治疗中的雌激素转化.
- 确定17β-基固醇脱酶14 (HSD17B14) 在乌尔索酸的疗效中的作用.
主要方法:
- 在使用西方饮食的小鼠模型中诱导了MASLD.
- 随着时间的推移,对HSD17B14,雌激素 (E1,E2) 水平和炎症进行了监测.
- 乌尔索酸干预的效果在脂肪性肝细胞中进行了评估.
主要成果:
- HSD17B14表达式波动,与E1和E2水平的变化相关.
- 乌尔索酸降低了HSD17B14和E1,同时增加了E2水平.
- E1促进了炎症;E2具有抗炎作用,但HSD17B14对抗了E2的益处.
结论:
- HSD17B14酶将E2转化为E1,使代谢压力诱导的炎症恶化.
- 乌尔索酸调节HSD17B14的活动,从而改变雌激素平衡.
- 这种由乌尔索酸的调制改善了MASLD中的免疫相关炎症.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
473
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
473
Drugs for Treatment of Ulcerative Colitis in IBD
109
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
109
Drug Metabolism: Phase II Reactions
3.5K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.5K
Cholesterol: Significance and Regulation
461
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
461
Overview of Fatty Acid Metabolism
30.0K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
30.0K
Transducer Mechanism: Nuclear Receptors
1.2K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.2K


